Canine Skin & Coat Framework

Canine Skin & Coat Framework · Version 1.1.0

Current label and serving facts: Pet Gala lists a 150 mg total Omega 3-6-9 blend per full sachet—not a 150 mg EPA/DHA dose. The displayed routine is Lite (under 7 lb or sensitive): ½ sachet daily; Standard (7–30 lb): 1 sachet daily; Double (30 lb+ dogs): 2 sachets daily. Those routines correspond to 75, 150, or 300 mg of total blend. Individual EPA and DHA quantities are not available, so no EPA/DHA dose-matching or finished-product effect is claimed. Hollywood Elixir lists quercetin at 25 mg per full sachet; that is a composition fact, not proof of dose-matched safety or efficacy.

Authorship boundary: Developed by La Petite Labs, with named veterinary contributions only where explicitly identified. Veterinary passages and case material are preserved verbatim; La Petite Labs editorial clarifications are separately labeled and are not quotations from veterinary contributors.

LPL-01™ Companion-Care Standard · La Petite Labs — Advanced Dermal Matrix & Barrier System

At a Glance

As a general practice veterinarian, the most common complaints I address at appointments relate to skin and coat health. Many owners feel they have "tried it all." The reality is that the skin and coat are complex living biological systems, and therefore often require multiple, simultaneous strategies to promote health. This article covers those strategies with a specific focus on what nutrition and supplementation can (and cannot) do, as well as the physiologic mechanisms at play. — Dr. Sarah Calvin, DVM

A dog's skin is a living organ system — the largest by surface area and one of the most metabolically active. It renews its outer layers every 21–28 days, synthesizes antimicrobial peptides, regulates temperature, and serves as the body's outermost barrier against environmental insult. When that system is well-supplied — structurally sound, lipid-rich, immunologically balanced — the result is visible: a dense, lustrous coat, comfortable skin, and a dog that is not chronically scratching, licking, or shedding.

This page documents the biology behind that outcome. It maps each layer and subsystem of the canine integument, identifies the nutritional inputs that support normal structure and function, and explains how the La Petite Labs formulation architecture aligns to those biological requirements. Where evidence is strong, we say so. Where it is preliminary or translational, we say that too.

How We Interpret Evidence

All ingredient-class claims on this page carry an evidence grade. We apply these conservatively:

Grade Definition Example
A Controlled trials conducted in dogs (or cats, on the feline page), published in peer-reviewed veterinary journals. Direct species-specific evidence. Omega-3 supplementation reducing pruritus scores in dogs with atopic dermatitis (Mueller et al., 2004; Bauer, 2011)
B Multi-species mammalian data with strong biological plausibility for dogs. May include equine, porcine, or rodent models where canine physiology is closely analogous. Collagen peptide supplementation supporting dermal density (mammalian fibroblast studies with cross-species applicability)
C Human clinical data, in-vitro mechanistic studies, or limited translational evidence. Biologically reasonable but not yet confirmed in the target species. Oral ceramide supplementation improving barrier lipid composition (human RCTs, canine mechanism plausible but unconfirmed)

What "translational evidence" means: A finding established in one species (often humans or rodents) that has a reasonable biological basis for applying to another (here, dogs). Translational evidence is not proof — it is a scientifically grounded hypothesis. We never present Grade C evidence as confirmed canine science.

The Canine Integumentary System: Barrier Biology and Control Layers

What does healthy canine skin actually do?

The canine skin is not a passive wrapper. It is an active, multi-layered organ system performing at least six critical functions simultaneously:

  1. Physical barrier — The stratum corneum (outermost dead-cell layer) forms a "brick-and-mortar" structure: corneocytes (bricks) embedded in a lipid matrix of ceramides, cholesterol, and free fatty acids (mortar). This barrier prevents transepidermal water loss (TEWL) and blocks microbial and allergen penetration (Marsella et al., 2011). [A]
  2. Antimicrobial defense — Keratinocytes produce antimicrobial peptides (β-defensins, cathelicidins) that regulate the skin microbiome and resist pathogen colonization.
  3. Immune surveillance — The skin houses Langerhans cells, dermal dendritic cells, mast cells, and resident T-cells that patrol for foreign antigens. In healthy skin, this system is calibrated to respond proportionally — not overreact. IL-31 mediated itch pathways are tightly regulated. [A]
  4. Thermoregulation — Dermal vasculature, eccrine glands (foot pads), and the insulating coat layer manage heat dissipation.
  5. Sensory interface — Mechanoreceptors, nociceptors, and pruriceptors relay environmental data to the central nervous system.
  6. Structural renewal — Epidermal turnover (21–28 day cycle in dogs), follicular cycling, and dermal matrix remodeling require continuous nutritional inputs: amino acids, fatty acids, zinc, B-vitamins, retinoids, and sulfur-containing compounds.

How is canine skin structured, layer by layer?

Epidermis — Thinner than in humans (3–5 cell layers in haired skin vs. 10–15 in humans), making dogs more vulnerable to barrier disruption. The basal layer continuously generates keratinocytes that migrate upward, differentiate, and terminally cornify.

Dermis — The structural core. Dense with collagen (primarily types I and III), elastin, glycosaminoglycans (including hyaluronic acid), fibroblasts, and an extensive vascular and nerve network. Dermal health determines skin elasticity, wound-healing capacity, and follicle support.

Hypodermis — Subcutaneous fat provides insulation, energy reserves, and mechanical cushioning for the dermal layer above.

Hair follicles — Dogs have compound follicles (one primary guard hair, multiple secondary hairs). Follicular cycling (anagen → catagen → telogen → exogen) is influenced by photoperiod, hormones, nutrition, and health status.

What makes the skin barrier fail?

Barrier dysfunction — whether from genetic predisposition, environmental exposure, nutritional insufficiency, or immune dysregulation — follows a recognizable cascade:

  1. Lipid-matrix depletion (ceramide deficiency, omega-3/omega-6 imbalance)
  2. Increased transepidermal water loss → dehydration of stratum corneum
  3. Allergen and microbial penetration through compromised mortar layer
  4. Immune activation → inflammatory cytokine release (IL-31, IL-4, IL-13, TSLP)
  5. Pruritus → scratching/licking → mechanical barrier damage → secondary infection risk
  6. Cycle self-perpetuates

This "itch–scratch–barrier damage" cycle is the central problem in canine atopic dermatitis, one of the most common skin conditions seen in veterinary practice (Hensel et al., 2015; Olivry et al., 2015). Nutritional support targets the upstream inputs (lipid supply, antioxidant defense, structural protein precursors) to help maintain barrier integrity before the cascade begins. [A]

Systems Map: Canine Dermal Matrix & Barrier Architecture

■ Formulation Architecture Mapping (Block 1A)

How LPL-01 maps to the Canine Dermal Matrix & Barrier Architecture:

The Systems Map above identifies six functional subsystems. The LPL-01 formulation maps nutritional inputs to each; this is architecture mapping, not finished-product efficacy:

Subsystem (from Systems Map) LPL-01 Pillar Primary Actives Delivered Mechanism
Matrix (Collagen, Elastin, GAGs) Structural matrix Marine Collagen Peptides 500mg (PG), Beef Gelatin 200mg (PG), Bone Broth 100mg (PG), Hyaluronic Acid 50mg (PG), Vitamin C 10mg (HE), Silica 10mg (PG) Provides bioavailable peptide precursors for dermal collagen and GAG synthesis; Vit C is prolyl/lysyl hydroxylase cofactor; silica supports cross-link scaffolding; supports fibroblast activity. ⊘ Copper — lysyl oxidase cofactor — not in LPL-01; cross-link maturation relies on endogenous copper from base diet
Keratin (Sulfur amino acids, Biotin, Zinc) Keratin integrity Biotin 50mcg (PG), Zinc chelated 1.5mg (PG), MSM 100mg (PG), Silica 10mg (PG), Hydrolyzed Whey Protein 250mg (PG), Whey Protein Isolate 250mg (HE) Supplies sulfur for disulfide cross-linking in keratin (MSM + sulfur-amino-acid fractions from whey/gelatin); zinc as metalloenzyme cofactor for keratinocyte differentiation; biotin as carboxylase cofactor
Lipid Barrier (Ceramides, EFA, Cholesterol) Barrier lipids Omega 3-6-9 blend 150mg total per full sachet (PG; contains EPA/DHA, GLA and LA; individual EPA and DHA quantities are undisclosed); Omega-7 Palmitoleic Acid 50mg (PG); Ceramides 8mg (PG) Ingredient-class fatty-acid rationale includes ceramide synthesis and lipid-matrix composition; Pet Gala's fatty-acid component quantities are undisclosed. Pet Gala separately lists preformed ceramides. No finished-product TEWL effect is inferred.
Hydration (GAG water binding, lipid-barrier control of TEWL) Hydration support Hyaluronic Acid 50mg (PG), Ceramides 8mg (PG), Omega 3-6-9 blend 150mg total per full sachet (PG; component quantities undisclosed) HA is a water-binding GAG substrate; ceramides and fatty-acid classes are relevant to barrier integrity and TEWL. This is substrate/barrier rationale, not direct aquaporin modulation or a finished-product hydration outcome.
Immune Tone (Resolvins, Antioxidant defense, IL-31 modulation) Immune calibration + Antioxidant defense EPA/DHA component of PG's 150 mg total Omega 3-6-9 blend per full sachet (individual EPA and DHA quantities undisclosed; ingredient-class mapping only), Vitamin E 15 IU (HE), Quercetin 25mg (HE), Vitamin C 10mg (HE), Astaxanthin 2mg (HE), Glutathione 50mg (HE), Resveratrol 15mg (HE), CoQ10 40mg (HE), Beta Glucans 50mg (HE), Reishi Mushroom 25mg (HE), Spirulina 50mg (HE), Zinc chelated 1.5mg (PG) EPA and DHA are ingredient-class resolvin/protectin precursors; Pet Gala's component quantities are undisclosed and no finished-product pro-resolving effect is inferred; Vitamin E provides membrane protection; Glutathione provides endogenous thiol antioxidant capacity; Zinc supports SOD-family antioxidant enzymes; quercetin provides mast-cell stabilization. ⊘ Selenium — not in LPL-01. Selenium is required for selenium-dependent glutathione peroxidases. Zinc/Cu-Zn-SOD and glutathione support separate antioxidant systems but do not replace selenium-dependent GPx activity; dietary selenium adequacy is expected from a complete and balanced primary diet.
Repair & Turnover (21–28 day cycle, follicular cycling) Turnover & repair support Zinc chelated 1.5mg (PG), Biotin 50mcg (PG), HE B-vitamin complex: Riboflavin/B2 0.5mg, Niacin/B3 2mg, B6 1mg, B12 0.25mg; NR (Nicotinamide Riboside) 60mg (HE); Whey Protein Isolate 250mg (HE), Hydrolyzed Whey Protein 250mg (PG), Marine Collagen Peptides 500mg (PG), Beef Gelatin 200mg (PG), Bone Broth 100mg (PG) Zinc and Biotin regulate epidermal proliferation and keratinocyte differentiation; HE B-vitamins and NR support cellular energy and NAD+ metabolism for rapid turnover; protein fractions supply amino-acid substrate for tissue renewal. ⊘ Vitamin A/Retinol — epithelial cell turnover regulator — not in LPL-01; Biotin (PG) and Vitamin E (HE) address keratinocyte function via different pathways. ⊘ Iron — not in LPL-01; mentioned for completeness as a cofactor for collagen prolyl hydroxylase

Design logic: The formulation does not target one subsystem in isolation. Structural matrix, keratin integrity, barrier lipids, hydration control, immune tone (including antioxidant defense), and turnover/repair are mapped together because barrier failure is a cascade — lipid depletion leads to TEWL increase leads to allergen penetration leads to immune activation leads to barrier damage. Interrupting the cascade requires multi-point nutritional input.

Mapping Biological Factors to Observable Signs — and Their Nutrient-Class Inputs

The table below is a general-biology map — it catalogues the nutrient classes that canine integumentary science identifies as relevant to each biological factor, irrespective of which specific product supplies them. Several inputs listed here (Selenium, Vitamin A/retinol, Iron, Copper, Prebiotic fiber) are NOT present in the LPL-01 formulation; they are included for scientific completeness. LPL-01-specific attribution is handled in the Formulation Crosswalk (Block 1B) that follows.

Biological Factor What the Owner Sees Key Nutritional Inputs Evidence Grade
Ceramide / lipid-matrix integrity Dry, flaky skin; dull coat; dandruff Omega-6 (LA, GLA), Omega-3 (EPA/DHA), Ceramide precursors [A] for defined EFA interventions (Mueller 2004); [B/C] for Idée 2022, a topical multi-ingredient experimental tape-stripping model—not oral-ceramide or finished-product evidence
Transepidermal water loss (TEWL) Rough, dehydrated skin; visible scaling Hyaluronic acid, EFA balance, adequate hydration [B]
Keratin structure Brittle coat, slow regrowth, split ends Biotin, Sulfur-amino acids (methionine, cysteine), Zinc [A] (Frigg et al., 1989)
Collagen / dermal matrix density Thin-feeling skin, slow wound healing, loss of elasticity Collagen peptides, Vitamin C, Copper [C] human translational evidence; no canine or finished-product effect established
Immune calibration (IL-31, Th2 skewing) Chronic itch, redness, hot spots, recurrent ear inflammation EPA/DHA (resolvin precursors), Vitamin E, Selenium, Quercetin [A] (Bauer, 2011; Olivry et al., 2015)
Antioxidant defense Premature graying, oxidative coat damage, slow recovery Vitamin E, Vitamin C, Selenium, Astaxanthin, Polyphenols [B]
Follicular cycling Excessive shedding, patchy regrowth, seasonal coat failure Zinc, Biotin, Vitamin A, Iron, Protein adequacy [A/B]
Microbial balance Yeasty smell, greasy patches, recurrent superficial pyoderma Zinc, Omega-3s, Prebiotic fiber (systemic context) [B]

■ Formulation Crosswalk (Block 1B)

How each biological factor maps to the LPL-01 ingredient architecture:

The table above links biology to observable signs and nutrient classes. The following crosswalk shows how the LPL-01 formulation addresses each biological factor through specific actives, and identifies the evidence-grade ceiling for each pathway.

Biological Factor LPL-01 Active(s) Formulation Pillar Pathway Summary Evidence Ceiling
Ceramide / lipid-matrix integrity Omega 3-6-9 blend 150mg total per full sachet (PG; contains EPA/DHA, GLA and LA; individual EPA and DHA quantities are undisclosed); Omega-7 Palmitoleic Acid 50mg (PG); Ceramides 8mg (PG) Barrier lipids EFAs have ingredient-class relevance to ceramide synthesis and lipid-matrix maintenance; Pet Gala's fatty-acid component quantities are undisclosed and no finished-product effect is inferred; Omega-7 supports sebaceous lipid composition; preformed ceramides contribute directly to stratum corneum lipid matrix [A] — EFA ingredient-class canine dermatitis trials; no finished-product Pet Gala grade; [C] — translational (oral ceramides)
Transepidermal water loss (TEWL) Hyaluronic Acid 50mg (PG), Ceramides 8mg (PG), Omega 3-6-9 blend 150mg total per full sachet (PG; component quantities undisclosed), Omega-7 Palmitoleic Acid 50mg (PG) Structural matrix + Barrier lipids HA supports dermal hydration; preformed ceramides reinforce the stratum corneum lipid matrix; EFA balance has ingredient-class relevance to lipid-matrix maintenance; Pet Gala's fatty-acid component quantities are undisclosed and no finished-product TEWL effect is inferred [B] — Mammalian TEWL/HA data
Keratin structure Biotin 50mcg (PG), Zinc chelated 1.5mg (PG), MSM 100mg (PG), Silica 10mg (PG), Beef Gelatin 200mg (PG), Marine Collagen Peptides 500mg (PG), Hydrolyzed Whey Protein 250mg (PG) Keratin integrity Biotin as carboxylase cofactor for fatty-acid synthesis in keratinocytes; zinc for metalloenzyme-dependent differentiation; MSM as sulfur donor for disulfide cross-linking; silica supports connective-tissue scaffolding; gelatin/collagen/whey supply sulfur-amino-acid substrate [A] (biotin, zinc) / [C] (MSM, silica)
Collagen / dermal matrix density Marine Collagen Peptides 500mg (PG), Beef Gelatin 200mg (PG), Bone Broth 100mg (PG), Hyaluronic Acid 50mg (PG), Vitamin C 10mg (HE), Silica 10mg (PG) Structural matrix Collagen peptides provide bioavailable proline/hydroxyproline; Vitamin C is cofactor for prolyl/lysyl hydroxylase; HA supplies GAG substrate; silica supports cross-linking scaffold. ⊘ Copper — lysyl oxidase cross-linking cofactor — not in LPL-01; cross-link maturation relies on endogenous copper from base diet [B] — Mammalian fibroblast data
Immune calibration (IL-31, Th2 skewing) EPA/DHA component of PG's 150 mg total Omega 3-6-9 blend per full sachet (individual EPA and DHA quantities undisclosed; ingredient-class mapping only), Vitamin E 15 IU (HE), Quercetin 25mg (HE), Glutathione 50mg (HE), Beta Glucans 50mg (HE), Reishi Mushroom 25mg (HE) Immune calibration EPA/DHA are ingredient-class precursors of resolvins/protectins; PG component quantities are undisclosed; Vitamin E → membrane protection; Glutathione → endogenous thiol redox buffering; Beta Glucans / Reishi → innate-immune tone modulation; Quercetin → mast-cell stabilization. ⊘ Selenium — not in LPL-01. Selenium is required for selenium-dependent glutathione peroxidases. Zinc/Cu-Zn-SOD and glutathione support separate antioxidant systems but do not replace selenium-dependent GPx activity; dietary selenium adequacy is expected from a complete and balanced primary diet. [A] (EPA/DHA ingredient class; finished Pet Gala product ungraded) / [B] (Vit E, Glutathione) / [C] (quercetin, beta-glucans)
Antioxidant defense Vitamin E 15 IU (HE), Vitamin C 10mg (HE), Astaxanthin 2mg (HE), Glutathione 50mg (HE), CoQ10 40mg (HE), Resveratrol 15mg (HE), Quercetin 25mg (HE), Blueberry Powder 50mg (HE), Spirulina 50mg (HE), Zinc chelated 1.5mg (PG) Antioxidant defense Multi-compartment coverage: Vit E (lipid phase), Vit C (aqueous phase), astaxanthin (membrane-spanning), Glutathione (intracellular thiol), CoQ10 (mitochondrial), Resveratrol/Quercetin/Blueberry polyphenols (circulating), Zinc (SOD cofactor). ⊘ Selenium — not in LPL-01. Selenium is required for selenium-dependent glutathione peroxidases. Zinc/Cu-Zn-SOD and glutathione support separate antioxidant systems but do not replace selenium-dependent GPx activity; dietary selenium adequacy is expected from a complete and balanced primary diet. [B]
Follicular cycling Zinc chelated 1.5mg (PG), Biotin 50mcg (PG), HE B-vitamin complex: Riboflavin/B2 0.5mg, Niacin/B3 2mg, B6 1mg, B12 0.25mg; NR (Nicotinamide Riboside) 60mg (HE); Whey Protein Isolate 250mg (HE), Hydrolyzed Whey Protein 250mg (PG), Silica 10mg (PG) Turnover & repair Zinc and Biotin regulate keratinocyte proliferation and hair shaft keratinization; HE B-vitamins and NR supply cellular energy / NAD+ for rapid follicular turnover; protein fractions supply amino-acid substrate; silica supports connective-tissue scaffolding around the follicle. ⊘ Vitamin A/Retinol — not in LPL-01; keratinocyte function addressed via Biotin (PG) and Vitamin E (HE) via different pathways. ⊘ Iron — not in LPL-01; mentioned for completeness as a cofactor for collagen prolyl hydroxylase [A/B]
Microbial balance Zinc chelated 1.5mg (PG), EPA/DHA component of PG's 150 mg total Omega 3-6-9 blend per full sachet (individual EPA and DHA quantities undisclosed; ingredient-class mapping only), Beta Glucans 50mg (HE), Reishi Mushroom 25mg (HE), Spirulina 50mg (HE) Immune calibration + systemic context Zinc for antimicrobial peptide synthesis; omega-3 has ingredient-class immune-tone rationale; PG's omega-3 component quantities are undisclosed; beta-glucans and reishi polysaccharides for innate-immune priming relevant to cutaneous microbial balance. ⊘ Prebiotic fiber — gut-mediated immune influence pathway — not in LPL-01; microbiome–skin axis is addressed via innate-immune-tone inputs rather than fermentable fiber [B]

Reading this crosswalk: The "Evidence Ceiling" column shows the highest available evidence grade for the connection between the active and the biological factor. Where the ceiling is [A], there is direct canine trial evidence. Where it is [B] or [C], the connection is biologically grounded but relies on translational or mechanistic data. We do not overclaim.

How Clinicians Measure Skin & Coat Status in Dogs

Veterinary dermatologists use several tools and scales to objectively assess integumentary health. Understanding these helps owners track progress and communicate more precisely with their veterinary team.

  • TEWL (Transepidermal Water Loss): Measured with a Tewameter or VapoMeter probe; quantifies barrier function. Higher TEWL = more compromised barrier. Values vary by body site; serial measurements track improvement over time. Currently used primarily in research settings rather than routine clinical practice, but provides objective barrier-function data in dermatology studies. [A]
  • Pruritus VAS (Visual Analogue Scale): Owner-reported itch severity on a 0–10 scale. Simple, validated, and widely used in dermatology trials. A 2-point or greater reduction is generally considered clinically meaningful.
  • CADESI-04 (Canine Atopic Dermatitis Extent and Severity Index): Veterinary-scored assessment of erythema, lichenification, and excoriation across 20 body sites. Used primarily in clinical trials and specialist dermatology. [A]
  • Lesion scoring: Counting and grading individual lesion types — papules, pustules, crusts, alopecic patches — provides objective tracking between visits.
  • Coat-quality assessment: Semi-quantitative evaluation of shine, density, texture, and undercoat condition. Not yet standardized but clinically informative when tracked longitudinally.
  • Seasonal recurrence mapping: Documenting when flares occur (spring/fall allergen peaks, winter dryness, summer humidity) reveals patterns that guide both medical and nutritional strategy.
  • Cytology (impression smears, skin scrapes, fluid analysis of pustules, and fine-needle aspirates of lesions): Microscopic evaluation of skin surface and lesion contents for Malassezia yeast, cocci, rods, or inflammatory cells. Fast, inexpensive, and clinically decisive for distinguishing infection from allergy and guiding treatment selection.
  • Trichogram (hair pluck analysis): Microscopic examination of plucked hairs to assess follicular cycling phase, shaft defects, and dermatophyte infection.

Owners can contribute by photographing the same body areas under consistent lighting at regular intervals and tracking pruritus VAS scores weekly.

What Causes Canine Skin & Coat Problems?

Skin and coat issues in dogs are rarely single-cause. They typically arise from the interaction of genetics, environment, immune programming, and nutritional status:

Genetic predisposition: Certain breeds carry elevated risk for barrier dysfunction. Bulldogs, West Highland White Terriers, Labrador Retrievers, Golden Retrievers, German Shepherds, and Shar-Peis all show higher incidence of atopic dermatitis and related skin conditions. Filaggrin-like protein deficiencies (analogous to human eczema genetics) have been investigated in some breeds.

Environmental triggers: Seasonal pollens, dust mites, mold spores, and flea saliva are the most common environmental allergens. Geographic climate (arid vs. humid) also influences baseline barrier hydration.

Dietary factors: Both deficiency (inadequate EFAs, zinc, protein) and sensitivity (adverse food reactions to specific proteins or additives) can manifest as skin and coat problems. Nutritional optimization is relevant in both scenarios — supporting barrier biology regardless of the trigger.

Immune dysregulation: Atopic dermatitis involves Th2-skewed immune responses, with IL-4, IL-13, and IL-31 driving inflammation and itch. Supporting immune balance through anti-inflammatory nutritional inputs (omega-3-derived resolvins and protectins) is a well-studied adjunctive strategy. [A]

Age-related changes: Senior dogs experience declining collagen synthesis, reduced sebaceous output, slower epidermal turnover, and often cumulative oxidative damage — all affecting skin and coat quality.

Common Owner Myths & Misinterpretations (Canine)

"My dog's coat is dull because of the shampoo I'm using." While harsh surfactants can strip coat oils, a persistently dull coat is far more often a reflection of internal nutritional status — EFA balance, protein adequacy, and micronutrient supply — than external product choice.

"Shedding means something is wrong." Shedding is a normal part of follicular cycling. Breed, photoperiod, and season are the primary drivers. Excessive or patchy shedding, however, warrants investigation into nutritional, hormonal, or dermatologic causes.

"Itching is always allergies." Pruritus has a broad differential diagnosis: ectoparasites (fleas, mites), bacterial or yeast infection, contact irritation, psychogenic causes, and pain can all present as scratching or licking. Assuming "allergies" without veterinary workup can delay diagnosis of treatable conditions.

"Grain-free diets are better for skin." There is no veterinary evidence that grain-free diets improve skin health in dogs without a confirmed grain sensitivity. In fact, some grain-free formulations have been associated with nutritional imbalances. Diet changes for skin should be guided by veterinary diagnosis, not marketing trends.

"If the supplement is working, I'll see results in a week." Skin biology operates on a 21–28 day epidermal turnover cycle. Meaningful coat and skin changes from nutritional optimization typically require 6–12 weeks of consistent supplementation. Early improvements in itch or comfort may emerge sooner, but full coat changes take time.

"Hot spots mean my dog needs a supplement." Acute moist dermatitis (hot spots) is typically a secondary condition triggered by self-trauma, underlying allergy, or infection. It requires veterinary treatment — often clipping, topical therapy, and sometimes antibiotics. Nutritional support can help with the underlying predisposition, but a hot spot itself needs medical care.

Clinical Perspective (DVM Co-Author)

Sarah Calvin, DVM — based on general practice experience with canine dermatology cases.

On owner expectations for skin/coat supplements. Two types of expectations: (1) Expectation that a supplement alone will solve the problem. Skin issues almost always require a multimodal solution. (2) If the supplement alone doesn't work, it isn't worth it. When used as part of a treatment plan, a supplement can be a great addition.

Give it time. It's hard to wait for weeks to see if a treatment plan will work, yet it is necessary. Medications can be provided to help control symptoms while you wait.

Track symptoms. Even dramatic results are hard to visualize when they take weeks to manifest. Taking pictures, filling out itch scores, and keeping a log of symptoms helps quantify the progress being made. Pet owners often feel disappointed in the outcomes of treatment of dermatologic conditions until they look at old photos of their pet. Small changes each day are hard to notice.

On nutritional intervention patterns. My favorite dietary interventions are (1) a novel protein diet and (2) fatty acid supplementation. Food allergies in dogs are often a reaction to the protein source in their diets. The most common allergens are chicken, beef, and dairy. Try a food that only includes protein sources your pet has never had. Prescription hydrolyzed diets may be a good option for pets that have been exposed to many protein sources as they contain broken down protein that is less likely to be recognized by the immune system. Essential fatty acids are helpful in many dermatology cases, especially cases of atopic dermatitis. I can often decrease the dose of the pet's immunosuppressive drugs when owners supplement with fatty acids at home.

On the most common diagnostic error with itchy dogs. You need to address all causes of itch: (1) treat any infections/infestations, (2) get rid of the inciting cause, (3) restore the skin barrier. Too often, owners, and even veterinarians, get tunnel vision on one piece of the dermatologic picture. Failure to address all causes of itch will unnecessarily prolong treatment.

On the timeline of nutritional response and breed-specific patterns. Mark your calendar for 8 weeks after making a nutritional change. Welcome any improvements you see before that date, but really wait for the 8-week mark to see if your dog will benefit from a nutritional change. Remember, it is normal to see ups and downs in your dog's skin and coat. Flare ups in genetically prone breeds like Bulldogs, Labradors, and West Highland Terriers are not uncommon, even when you are doing everything right.

Clinical Vignette: Rosey (Canine)

Case contributed by Sarah Calvin, DVM

Rosey, a 10-year-old, 14 lb, spayed female Shi Tzu, presented after a 2-week history of redness in all four paws and head shaking. Owner noted that in the last few months Rosey had decreased energy, hair thinning on her abdomen, and a mild, generalized itchiness. She had no significant medical history other than mild seasonal skin dryness and redness between paw pads. Rosey was on a regular flea preventative, had no recent changes to diet, and received no supplements or medications.

Physical exam revealed redness, discharge, and swelling of the skin in the ears, skin folds, and paws: bilateral otitis externa, skin fold dermatitis, and pododermatitis. The fur on her ventral abdomen was thinning, but the underlying skin appeared healthy. Cytologic exam revealed mixed fungal (yeast) and bacterial (cocci and rods) infections in all three infected locations. Flea comb examination, skin scrape, and fungal culture were negative, ruling out ectoparasites and dermatophytosis.

To address Rosey's decreased energy and unexplained onset of symptoms, a full physical exam was performed as well as a complete blood count (CBC), chemistry panel, thyroid panel, and ACTH stimulation. Rosey had no evidence of heart disease, no signs of pain, and no evidence of weakness on physical exam. She had moderate tartar and some gingivitis and was scheduled for a dental cleaning. CBC, chemistry panel, and ACTH stimulation were all normal. Rosey's thyroid panel revealed a moderate hypothyroidism. This was suspected to be the catalyst for her changes in the last few months.

First, Rosey's infections were addressed. Medicated wipes were used on her paws and skin folds, and medicated ear drops were given in each ear. She was given two medicated baths as well. At her 10-day follow-up, owners noted that her pruritis score went from 5/10 to 2/10 and there were no visible signs of infection.

Next, Rosey's underlying cause — hypothyroidism — was addressed. She was started on a thyroid supplement. At a recheck four weeks later, her thyroid levels were within normal limits. Since Rosey also experienced seasonal paw redness, her owner was advised to wipe her paws after being outside.

Rosey's skin barrier was likely compromised from her hypothyroidism diagnosis and recent infections. To promote a healthy skin barrier, Rosey was transitioned to an AAFCO compliant food, started a regular bathing routine with an oatmeal-based shampoo, and began a fish oil supplement. This combination supported appropriate cell turnover, modulated the immune response, and minimized TEWL.

At her wellness exam six months later, owners reported that Rosey had a noticeably thicker coat, had less tangles and breakage, no itch, and her energy was restored.

Rosey's case demonstrates the importance of addressing all aspects of skin health: treating infection, discovering and resolving underlying causes, and optimizing nutrition and lifestyle factors to promote skin health and restore damaged components.

Integumentary Healthspan: The "Comfortspan" Concept

In veterinary wellness, "healthspan" refers to the years of comfortable, functional life — not just lifespan. For the integumentary system, we use the concept of Comfortspan: the duration of a dog's life during which the skin and coat function normally, without chronic discomfort, recurrent infections, or progressive deterioration.

Comfortspan is compressed by:

  • Chronic, unmanaged inflammation (progressive barrier degradation)
  • Cumulative oxidative damage (UV exposure, metabolic byproducts)
  • Age-related decline in collagen synthesis and epidermal turnover
  • Nutritional insufficiency sustained over months or years

Comfortspan is extended by:

  • Proactive nutritional support aligned to barrier biology
  • Timely veterinary diagnosis and treatment of underlying conditions
  • Environmental management (allergen reduction, appropriate grooming)
  • Consistent monitoring (owner observation + periodic veterinary assessment)

The goal of nutritional optimization is not to treat disease. It is to maintain the biological inputs the skin requires for normal function — so that the barrier, the immune system, and the repair machinery operate within their optimal range for as long as possible.

LPL-01 Formulation Architecture: How Pet Gala Aligns to These Pillars

Our formulation is designed to supply the nutritional inputs mapped above — not as a treatment for any condition, but as structured support for the normal biological processes that sustain skin and coat health. Each active ingredient class targets a specific subsystem in the dermal matrix and barrier architecture.

Product Architecture: Ingredient-to-System Mapping

Pillar Primary Actives Biological Target Evidence
Barrier lipids Omega 3-6-9 blend 150mg total per full sachet (PG; contains EPA/DHA, GLA and LA; individual EPA and DHA quantities are undisclosed); Omega-7 Palmitoleic Acid 50mg (PG); Ceramides 8mg (PG) Ingredient-class barrier-lipid rationale plus separately listed preformed ceramides; Pet Gala's fatty-acid component quantities are undisclosed and no finished-product TEWL effect is inferred Ingredient-class evidence: [A] (EFA); [C] (oral ceramides, translational). Finished Pet Gala product ungraded.
Structural matrix Marine Collagen Peptides 500mg (PG), Beef Gelatin 200mg (PG), Bone Broth 100mg (PG), Hyaluronic Acid 50mg (PG), Silica 10mg (PG), Vitamin C 10mg (HE) Dermal density, GAG hydration, fibroblast support, prolyl/lysyl hydroxylase cofactor supply. ⊘ Copper — lysyl oxidase cross-linking cofactor — not in LPL-01 [B]
Keratin integrity Biotin 50mcg (PG), Zinc chelated 1.5mg (PG), MSM 100mg (PG), Silica 10mg (PG), Hydrolyzed Whey Protein 250mg (PG), Whey Protein Isolate 250mg (HE) Keratinocyte differentiation, hair shaft strength, sulfur-amino acid metabolism via MSM and whey/gelatin-derived methionine/cysteine [A] (biotin, zinc) / [C] (MSM, silica)
Immune calibration EPA/DHA component of PG's 150 mg total Omega 3-6-9 blend per full sachet (individual EPA and DHA quantities undisclosed; ingredient-class precursor rationale only; no finished-product pro-resolving effect is inferred), Vitamin E 15 IU (HE), Quercetin 25mg (HE), Glutathione 50mg (HE), Beta Glucans 50mg (HE), Reishi Mushroom 25mg (HE) Ingredient-class pathway map: pro-resolving lipid mediators, membrane antioxidant protection, thiol redox buffering, innate-immune tone and mast-cell biology. PG's EPA/DHA components are undosed; no finished-product pro-resolving effect is inferred. ⊘ Selenium — not in LPL-01. Selenium is required for selenium-dependent glutathione peroxidases. Zinc/Cu-Zn-SOD and glutathione support separate antioxidant systems but do not replace selenium-dependent GPx activity; dietary selenium adequacy is expected from a complete and balanced primary diet. Ingredient-class [A] (EPA/DHA); finished Pet Gala product ungraded / [B] (Vit E, Glutathione) / [C] (quercetin, beta-glucans)
Antioxidant defense Vitamin E 15 IU (HE, mixed tocopherols), Vitamin C 10mg (HE), Astaxanthin 2mg (HE), Glutathione 50mg (HE), CoQ10 40mg (HE), Resveratrol 15mg (HE), Quercetin 25mg (HE), Blueberry Powder 50mg (HE), Spirulina 50mg (HE), Zinc chelated 1.5mg (PG) ROS scavenging across lipid, aqueous, membrane-spanning, intracellular thiol, and mitochondrial compartments; lipid peroxidation prevention; UV-damage mitigation; SOD cofactor supply. ⊘ Selenium — not in LPL-01. Selenium is required for selenium-dependent glutathione peroxidases. Zinc/Cu-Zn-SOD and glutathione support separate antioxidant systems but do not replace selenium-dependent GPx activity; dietary selenium adequacy is expected from a complete and balanced primary diet. [B]
Turnover & repair support Zinc chelated 1.5mg (PG), Biotin 50mcg (PG), HE B-vitamin complex: Riboflavin/B2 0.5mg, Niacin/B3 2mg, B6 1mg, B12 0.25mg; NR (Nicotinamide Riboside) 60mg (HE); Whey Protein Isolate 250mg (HE), Hydrolyzed Whey Protein 250mg (PG), Marine Collagen Peptides 500mg (PG), Beef Gelatin 200mg (PG), Bone Broth 100mg (PG), MSM 100mg (PG), Hyaluronic Acid 50mg (PG), Silica 10mg (PG), L-Carnitine 20mg (PG) Epidermal renewal rate, follicular cycling support, keratinocyte differentiation, amino-acid substrate for tissue renewal, NAD+ metabolism for cellular energy, wound-healing cofactors. ⊘ Vitamin A/Retinol — epithelial cell turnover regulator — not in LPL-01; keratinocyte function addressed via Biotin (PG) and Vitamin E (HE) via different pathways. ⊘ Iron — not in LPL-01; mentioned for completeness as a cofactor for collagen prolyl hydroxylase [A/B]

Formulation notes:

  • Omega-3 to omega-6 ratio is calibrated to support anti-inflammatory pathways without suppressing protective inflammatory responses.
  • Zinc is provided in chelated form (zinc methionine or zinc picolinate) for improved bioavailability over zinc oxide.
  • Collagen peptides are hydrolyzed to low molecular weight for absorption.
  • No artificial colors, flavors, or preservatives.
  • Formulated for palatability and ease of daily administration.

■ Barrier System Integration Summary (Block 1E)

Why the formulation addresses multiple pillars simultaneously:

The canine dermal barrier is not a collection of independent subsystems — it is an integrated biological architecture where failure in one domain cascades into others. The LPL-01 formulation is designed around this integration logic:

Cascade 1: Lipid depletion → Barrier breach → Immune activation When lipid-matrix integrity fails (ceramide/EFA deficiency), TEWL increases, the stratum corneum dehydrates, and allergens penetrate more easily. This triggers immune activation (IL-31, Th2 cytokines), producing the itch–scratch–barrier damage cycle that defines atopic dermatitis. The formulation addresses this cascade at three points: barrier lipids (EFA supply), immune calibration (resolvin precursors), and antioxidant defense (membrane protection during inflammatory stress).

Cascade 2: Structural decline → Slow repair → Compounding damage When dermal matrix density declines (collagen loss, GAG depletion) and epidermal turnover slows (zinc, biotin, protein, and B-vitamin insufficiency), the skin loses its capacity to repair daily microtrauma. Damage accumulates faster than it is repaired. The formulation addresses this with structural matrix support (marine collagen peptides, beef gelatin, bone broth, hyaluronic acid, silica — all PG) and turnover/repair inputs (chelated zinc, biotin — PG; HE B-vitamins: riboflavin/B2, niacin/B3, B6, B12; NR/Nicotinamide Riboside — HE; whey protein isolate — HE). ⊘ Vitamin A and ⊘ Iron are not present in LPL-01; their roles are addressed through alternative pathways or acknowledged as out-of-scope for this formulation.

Cascade 3: Oxidative stress → Accelerated aging → Barrier degradation Chronic oxidative burden — from UV exposure, metabolic byproducts, or inflammation itself — damages lipid membranes, degrades collagen cross-links, and impairs the enzymatic antioxidant defenses. The formulation’s antioxidant-defense pillar includes vitamin E, vitamin C, astaxanthin, glutathione, CoQ10 and polyphenols across complementary non-GPx antioxidant compartments. Selenium is not supplied by LPL-01, so selenium-dependent GPx activity is not attributed to the formulation.

The integration principle: No single pillar of the LPL-01 formulation is intended to function in isolation. The six mapped systems — structural matrix, keratin integrity, barrier lipids, hydration control, immune tone (including antioxidant defense), and turnover/repair — are designed as a coordinated nutritional input that mirrors the integrated biology of the dermal barrier system.

This is a formulation architecture statement, not a therapeutic claim. The formulation supplies nutritional substrates to support normal biological function — it does not treat barrier disease.

What Nutrition Cannot Fix (Canine)

Nutritional support is one input into a complex biological system. It is not a substitute for veterinary diagnosis or medical treatment. Specifically, supplements cannot:

  • Treat ectoparasite infestation — Fleas, ticks, Demodex, Sarcoptes, and Cheyletiella require specific antiparasitic therapy. No supplement replaces parasiticide treatment.
  • Resolve active bacterial pyoderma — Superficial or deep pyoderma requires antimicrobial therapy (topical and/or systemic) guided by cytology or culture and sensitivity.
  • Cure fungal infection — Dermatophytosis (ringworm) and Malassezia overgrowth require targeted antifungal treatment.
  • Correct endocrine disease — Hypothyroidism, hyperadrenocorticism (Cushing's), and sex-hormone imbalances cause significant dermatologic signs that only resolve with appropriate hormonal management.
  • Replace immunotherapy — Allergen-specific immunotherapy (ASIT) for confirmed environmental allergies cannot be substituted by nutritional means.
  • Reverse immune-mediated skin disease — Pemphigus, lupus, and other autoimmune dermatoses require immunosuppressive therapy under veterinary supervision.
  • Remove tumors or growths — Cutaneous neoplasia requires surgical, medical, or radiation oncology intervention.
  • Overcome severe genetic barrier defects — Breeds with profoundly defective skin barriers (e.g., ichthyosis in Golden Retrievers) benefit from nutrition but cannot achieve normal barrier function through supplementation alone.

Supplements are adjunctive. They complement a veterinary diagnostic and treatment plan — they do not replace one.

■ Boundary Statement (Block 1C)

Where LPL-01 sits in the care hierarchy — and where it does not:

The following table clarifies the role of the LPL-01 formulation relative to veterinary medical intervention for common canine integumentary conditions.

Condition Veterinary Domain (Required) LPL-01 Nutritional Support Domain (Adjunctive) Boundary
Atopic dermatitis Diagnosis (intradermal/serology testing), immunotherapy (ASIT), pharmacotherapy (oclacitinib, lokivetmab, cyclosporine, corticosteroids) EFA supply for resolvin production, barrier lipid support, antioxidant defense Nutrition supports barrier biology and inflammatory tone; it does not replace immunomodulatory drugs or immunotherapy
Bacterial pyoderma Cytology, culture & sensitivity, systemic/topical antimicrobials Zinc for antimicrobial peptide support, EFAs for barrier restoration Nutrition supports post-treatment barrier recovery; it does not treat active infection
Ectoparasitic disease Antiparasitic treatment (isoxazolines, selamectin, etc.) Barrier-lipid support to help restore skin damaged by parasitic infestation Nutrition has no antiparasitic effect. Parasite control is prerequisite.
Endocrine alopecia Thyroid/adrenal diagnosis and hormone management Coat-protein and micronutrient support during hormonal treatment Nutrition cannot correct hormonal imbalance
Dermatophytosis Antifungal therapy (systemic and/or topical), environmental decontamination General skin-health support Nutrition does not treat fungal infection
Age-related coat decline Geriatric health screening to rule out underlying disease Full-spectrum barrier and matrix support (EFAs, collagen, zinc, biotin, antioxidants) This is the primary domain where nutritional support operates independently — supporting normal age-related maintenance when no disease is present

Summary principle: LPL-01 formulations operate in the nutritional-support domain — supplying substrates for normal biological function. When disease is present, veterinary diagnosis and treatment are the primary interventions. Nutritional support is adjunctive to, not a substitute for, medical care.

When to Escalate to a Veterinarian

Seek veterinary evaluation promptly if your dog shows any of the following:

  • Sudden, intense pruritus — Especially if generalized or accompanied by hives/angioedema (possible acute allergic reaction)
  • Spreading alopecia (hair loss) — Particularly if symmetric, rapidly progressive, or accompanied by skin thickening
  • Draining lesions, abscesses, or deep-tissue swelling — Signs of deep pyoderma or other serious infection
  • Non-healing wounds — Any wound that fails to progress through normal healing within 10–14 days
  • Significant behavioral change — Lethargy, inappetence, or withdrawal alongside skin changes may signal systemic disease
  • Skin masses or rapidly changing growths — Any new lump, pigmented lesion, or rapidly enlarging mass warrants evaluation
  • Persistent ear problems — Chronic otitis (head shaking, odor, discharge) despite home care suggests underlying allergy, anatomy, or infection issues
  • Skin changes with polyuria/polydipsia/polyphagia — Classic triad suggesting possible endocrine disease (Cushing's, diabetes)
  • Periocular, perioral, or perineal lesions — May indicate autoimmune, parasitic, or systemic disease patterns
  • Failure to respond to 8–12 weeks of appropriate nutritional optimization — Persistent signs despite quality nutrition suggest an underlying condition requiring medical diagnosis

Adjunctive Role Statement

La Petite Labs formulations are dietary supplements designed to support the normal structure and function of the canine integumentary system. They are not drugs, and they are not intended to diagnose, treat, cure, or prevent any disease.

Nutritional supplementation works best as one component of a comprehensive approach to skin and coat health that includes:

  • Appropriate veterinary diagnosis and treatment for any underlying conditions
  • Parasite prevention
  • Environmental management (allergen reduction, appropriate humidity, UV protection)
  • Breed-appropriate grooming
  • A complete and balanced base diet
  • Regular veterinary wellness examinations

When used as part of this integrated approach, structured nutritional support can help maintain the biological substrates — fatty acids, structural proteins, micronutrients, and antioxidants — that the skin requires for normal function and repair.

Safety & Dosing Guardrails

These principles guide responsible supplementation. They do not constitute specific dosing instructions — dosing should follow product labeling and veterinary guidance.

Omega balance: The ratio of omega-3 to omega-6 fatty acids matters. Excessive omega-3 without adequate omega-6 can impair normal inflammatory responses (which are necessary for wound healing and pathogen defense). Excessive omega-6 without adequate omega-3 can promote pro-inflammatory eicosanoid production. Balanced supplementation is the goal. [A]

Fat-soluble vitamin caution (A, D, E, K): These vitamins accumulate in body fat and liver tissue. Unlike water-soluble vitamins, excess intake is not readily excreted. Vitamin A toxicity in particular can cause skin and coat pathology (paradoxically) — including dry skin and hair loss. Stay within established safe upper limits. [A]

Zinc caution: Zinc is essential for skin health but has a relatively narrow therapeutic index in dogs. Excess zinc can interfere with copper absorption, potentially causing copper-deficiency anemia. Chelated forms improve bioavailability and reduce the dose needed. [A]

Allergy and palatability: Dogs with known food sensitivities should have supplement ingredient lists reviewed for potential allergens (fish, egg, soy, specific protein sources). Palatability affects compliance — the best supplement is one the dog will actually consume consistently.

Multi-supplement stacking: Owners using multiple supplements risk inadvertent overdosing of overlapping ingredients (zinc, vitamin E, omega-3). A veterinarian or veterinary nutritionist should review the full supplementation profile when more than one product is used concurrently.

Drug interactions: Omega-3 fatty acids at high doses may affect platelet function. Dogs on anticoagulant therapy, scheduled for surgery, or receiving immunosuppressive drugs should have supplementation reviewed by their veterinarian.

Explore the Science Library

Sources

Primary Sources

  1. Frigg M, Schulze J, Volker L. "Clinical study on the effect of biotin on skin conditions in dogs." Schweiz Arch Tierheilkd. 1989;131(10):621–625.
  2. Kim D-U, Chung H-C, Choi J, Sakai Y, Lee B-Y. "Oral Intake of Low-Molecular-Weight Collagen Peptide Improves Hydration, Elasticity, and Wrinkling in Human Skin: A Randomized, Double-Blind, Placebo-Controlled Study." Nutrients. 2018;10(7):826. PMID 29949889. DOI 10.3390/nu10070826. [Human study, 1,000 mg/day for 12 weeks; Grade C translational context only—not canine or dose-matched Pet Gala evidence. Two authors were employees of the tested-product supplier.]
  3. Combarros D, Castilla-Castaño E, Lecru LA, Pressanti C, Amalric N, Cadiergues MC. "A prospective, randomized, double blind, placebo-controlled evaluation of the effects of an n-3 essential fatty acids supplement (Agepi ω3) on clinical signs, and fatty acid concentrations in the erythrocyte membrane, hair shafts and skin surface of dogs with poor quality coats." Prostaglandins Leukot Essent Fatty Acids. 2020;159:102140. PMID 32505998. DOI 10.1016/j.plefa.2020.102140. [24 dogs; tested 110 mg EPA + 68 mg DHA daily; not dose-matched to Pet Gala. The corresponding author had previously consulted for the tested product’s manufacturer.]
  4. Mueller RS, Fieseler KV, Fettman MJ, et al. "Effect of omega-3 fatty acids on canine atopic dermatitis." J Small Anim Pract. 2004;45(6):293–297.
  5. Idée A, Mosca M, Pin D. "Skin Barrier Reinforcement Effect Assessment of a Spot-on Based on Natural Ingredients in a Dog Model of Tape Stripping." Veterinary Sciences. 2022;9(8):390. PMID 36006305. PMCID PMC9414208. DOI 10.3390/vetsci9080390. [Five healthy laboratory beagles; acute tape-stripping model; topical EFA/ceramide/essential-oil combination—not naturally occurring atopic dermatitis, oral ceramides, or Pet Gala. Partially industry funded.]
  6. Scott DW, Miller WH, Griffin CE. Muller & Kirk's Small Animal Dermatology. 7th ed. Elsevier Saunders; 2013. [Standard veterinary dermatology reference text.]
  7. Olivry T, DeBoer DJ, Favrot C, et al. "Treatment of canine atopic dermatitis: 2015 updated guidelines from the International Committee on Allergic Diseases of Animals (ICADA)." BMC Vet Res. 2015;11:210.
  8. Bauer JE. "Therapeutic use of fish oils in companion animals." J Am Vet Med Assoc. 2011;239(11):1441–1451.
  9. Watson TDG. "Diet and skin disease in dogs and cats." J Nutr. 1998;128(12 Suppl):2783S–2789S.
  10. Marsella R, Olivry T, Carlotti DN. "Current evidence of skin barrier dysfunction in human and canine atopic dermatitis." Vet Dermatol. 2011;22(3):239–248.
  11. Hensel P, Santoro D, Favrot C, et al. "Canine atopic dermatitis: detailed guidelines for diagnosis and allergen identification." BMC Vet Res. 2015;11:196.

LPL-01™ Companion-Care Standard · La Petite Labs · Canine Skin & Coat Science Last revised: July 2026 Veterinary contributor: Sarah Calvin, DVM